The Board of Directors of ASIT Biotech S.A. appointed Yves Désiront as interim CFO, while the company is looking for a new profile to replace Everard van der Straten, who supervised the financial organization of the company and its financing since its IPO in 2016. Everard van der Straten remains a Board member. Philippe Degeer to join the Board of Directors as representative of Meusinvest.